Division 3.8.2.1.7.3 Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, must be taken into consideration in the classification process, including but not limited to the following effects in humans and/or animals:
United Kingdom
- (a)
morbidity resulting from single exposure;
- (b)
significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);
- (c)
any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;
- (d)
significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;
- (e)
multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;
- (f)
morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;
- (g)
evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.